almotriptan
Sign in to saveAlso known as Axert®, LAS-31416, PNU-180638E, 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
Almotriptan, sold under the brand names Axert and Almogran among others, is a triptan medication used in the treatment of heavy migraine headache.
Research
311 papers- Almotriptan.2006
- Almotriptan: a review of 20 years' clinical experience.Expert review of neurotherapeutics · 2019
- Almotriptan.2026
- Almotriptan: a review of its use in migraine.Drugs · 2002
- Almotriptan, a new anti-migraine agent: a review.CNS drug reviews · 2002
via PubMed
Wikidata facts
- Mass
- 335.166748
Show 5 more facts
- chemical formula
- C₁₇H₂₅N₃O₂S
- Commons category
- Almotriptan
- canonical SMILES
- CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
- World Health Organisation international non-proprietary name
- almotriptan
- defined daily dose
- 12.5
via Wikidata · CC0
~5 min read
Article
14 sectionsContents
- Medical uses
- Effectiveness
- Contraindications
- Side effects
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Brand names
- References
- External links
Almotriptan, sold under the brand names Axert and Almogran among others, is a triptan medication used in the treatment of heavy migraine headache.
Almotriptan was patented in 1992 and approved for medical use in 2000. It was discovered and developed by Almirall-Prodesfarma.
Connections
tryptamines
Entity
N-methylserotonin
Entity
5-methoxytryptamine
Entity
α-methyl-5-HT
Entity
lysergic acid diethylamide
Entity
serotonin
Entity
mefloquine
Entity
adrenergic receptor
Entity
ergoline
Entity
indopan
Entity
etryptamine
Entity
glaucine
Entity
N,N-diisopropyltryptamine
Entity
MAOA
Gene
5-carboxamidotryptamine
Entity
azasetron
Entity
5-methoxy-α-methyltryptamine
Entity
5-(2-aminopropyl)indole
Entity
antimigraine
Entity
imidazoline receptors
Entity